Get started
Work

Supplemental Table 1 from Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial

Year: 2023
Type: supplementary-materials
Abstract: Cardiac treatment-emergent adverse events in the two trial groups
DOI: 10.1158/1078-0432.22480835.v1
Authors: Robin L. Jones, Andrew J. Wagner, Akira Kawai, Kazuo Tamura, Ashwin Shahir, Brian A. Van Tine, Javier Martín-Broto, Patrick M. Peterson, Jennifer Wright, William D. Tap
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361939489
Cites:
Cited by:
Related to: 10